Docoh
Loading...

PKI Perkinelmer

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Company profile

Ticker
PKI
Exchange
CEO
Prahlad Singh
Employees
Incorporated
Location
Fiscal year end
Former names
EG&G INC
SEC CIK
IRS number
42052042

PKI stock data

(
)

Calendar

2 Mar 21
18 Apr 21
29 Dec 21
Quarter (USD)
Jan 21 Oct 20 Jul 20 Apr 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Jan 21 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Perkinelmer earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
6 Apr 21 Goldberg Joel S Common Stock Payment of exercise Dispose F No No 130.99 504 66.02K 76,114
6 Apr 21 Mock James M Common Stock Payment of exercise Dispose F No No 130.99 543 71.13K 33,329
6 Apr 21 Vohra Tajinder S Common Stock Payment of exercise Dispose F No No 130.99 275 36.02K 12,697
6 Apr 21 Singh Prahlad R. Common Stock Payment of exercise Dispose F No No 130.99 882 115.53K 51,604
5 Feb 21 Vohra Tajinder S Common Stock Grant Aquire A No No 0 1,297 0 12,972
5 Feb 21 Vohra Tajinder S NQ Stock Option Common Stock Grant Aquire A No No 144.33 5,388 777.65K 5,388

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

93.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 581 519 +11.9%
Opened positions 108 105 +2.9%
Closed positions 46 41 +12.2%
Increased positions 196 161 +21.7%
Reduced positions 188 164 +14.6%
13F shares
Current Prev Q Change
Total value 14.98B 12.65B +18.4%
Total shares 104.41M 100.88M +3.5%
Total puts 140.6K 85.8K +63.9%
Total calls 201.4K 402K -49.9%
Total put/call ratio 0.7 0.2 +227.1%
Largest owners
Shares Value Change
Capital Research Global Investors 12.17M $1.75B +0.3%
Vanguard 12.14M $1.74B +1.3%
Select Equity 10.33M $1.48B +11.0%
BLK Blackrock 7.35M $1.05B +3.3%
STT State Street 4.42M $634.9M -2.0%
Massachusetts Financial Services 4.14M $594.47M +8.9%
TROW T. Rowe Price 3.32M $476.37M -40.4%
JHG Janus Henderson 3.23M $463.59M -14.3%
Pictet Asset Management 2.95M $423.1M +9.2%
King Luther Capital Management 2.28M $327.05M -4.8%
Largest transactions
Shares Bought/sold Change
TROW T. Rowe Price 3.32M -2.25M -40.4%
FMR 1.34M +1.25M +1411.9%
Select Equity 10.33M +1.02M +11.0%
Norges Bank 993.66K +993.66K NEW
Liontrust Investment Partners 853.31K +853.31K NEW
JHG Janus Henderson 3.23M -539.56K -14.3%
Robeco Institutional Asset Management B.V. 553.11K +502.43K +991.3%
Renaissance Technologies 0 -468.5K EXIT
Ceredex Value Advisors 1.25M +458.9K +58.3%
Assenagon Asset Management 458.56K +458.56K NEW

Financial report summary

?
Competition
WatersLuminexHarvard BioscienceNateraTodos Medical
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Abingdon, absence, absenteeism, academia, Academy, adulterant, Aflatoxin, Agency, agreed, antibiotic, AOAC, Appendix, AQ, aquaculture, Arab, attached, AuroFlow, automatic, BARRETT, battery, biodegradability, biomonitoring, blended, boast, Branch, Brazilian, bring, bucket, build, burden, Cairo, Cambridge, cardiovascular, CDS, CE, Centrifuge, Certificate, certification, CFR, chapin, charitable, Chloramphenicol, citizenship, Consent, convenience, Cooperation, corn, cream, CSR, CV, cybersecurity, DAC, delinquency, Deoxynivalenol, deviation, device, dialogue, disability, disinfecting, distancing, distraction, DON, duly, durum, Dynex, ease, edible, Elavon, embedded, EMEAI, encourage, encouraged, encouraging, endeavor, Engraining, EONISTM, equitable, essential, ethical, ethnic, EURORealTime, EvoyaTM, exhibit, extra, farmed, feedback, floor, flu, footprint, forget, freight, Fumonisin, gender, globe, gluten, Glutork, half, hereto, highest, home, Horizon, HTS, IgG, Immunotec, impeding, incentivizing, Indian, influenza, ingredient, inline, instance, Interferon, intervention, LactoScope, Language, latent, learning, Lender, linearity, Linkbase, Listeria, Luxembourg, manual, Maritime, Max, MaxSignal, mental, MICHEL, mid, Miriame, modern, modular, mono, month, MSD, multicultural, mycotoxin, nasal, nasopharyngeal, neuroscience, nontaxable, Ochratoxin, Official, omitted, Opportunistically, opportunity, organizational, orientation, oropharyngeal, outsized, Oxford, Page, pandemic, Panel, PASCALE, perten®, PETER, pharmacy, PharmD, PhD, pivotal, PKamp, PKampTM, plc, PlGF, proactive, professional, PTM, punch, QA, quantity, QuantiVacTM, race, racial, ramp, reassessment, recalculating, recommend, recruiting, rectifying, recyclability, registrar, relaxed, religion, remote, remotely, repayment, requested, roughly, RSV, Rupee, samuel, scalable, Schema, scheme, SCID, seafood, semolina, sex, sexual, shelf, shrimp, Signature, SimplicityChrom, SimplicityChromTM, singly, situation, skim, SM, SMA, spectrophotometer, Sr, stable, strip, strive, suspension, swab, Swing, SYLVIE, sync, tackle, taxonomy, temperature, thereto, thereunto, top, travel, Treasurer, true, trustee, turnaround, UK, undersigned, unified, unity, upward, vehicle, veteran, vi, vii, viral, vital, warning, whey, WITNEY, WITZ, workplace, XBRL, XLA, Zearalenone
Removed: abandon, accreted, AG, Assignment, authoritative, backlog, Bath, compute, conditional, council, Deborah, decided, deep, depreciated, diploma, exclude, expand, founded, function, geography, HR, IBM, immunoassay, investee, involvement, Italy, Labordiagnostika, largest, leasing, led, lengthy, Medizinische, Mine, North, occupying, owner, partner, positioned, prepared, project, purport, quantitative, reimbursed, relation, representing, reserving, Resource, reversed, robust, shape, sustained, Suzhou, Switzerland, talent, transformation, transitional, TRF, uncollectible, Unresolved, Varex, Varian